Adenomatous Polyposis Coli Clinical Trial
— KOPOFOfficial title:
KOPOF Registry (Patients Characteristics, Operative Data, Postoperative Outcome, Functional Postoperative Recovery ) of Patients in Which a Pouch Has Been Created Due to Colitis Ulcerosa (CU) or Familial Adenomatous Polyposis(FAP)
NCT number | NCT01604564 |
Other study ID # | S-54228 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | May 2012 |
Est. completion date | January 2019 |
Verified date | October 2021 |
Source | Universitaire Ziekenhuizen Leuven |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The purpose of this registry is to collect information about patients in which a pouch has been created to improve in the future the quality of the surgery of the pouch.
Status | Completed |
Enrollment | 207 |
Est. completion date | January 2019 |
Est. primary completion date | July 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - Colitis Ulcerosa or Familial Adenomatous Polyposis Patients With IPAA Exclusion Criteria: - No |
Country | Name | City | State |
---|---|---|---|
Belgium | University Clinics Gasthuisberg | Leuven | Flemish Brabant |
Lead Sponsor | Collaborator |
---|---|
Universitaire Ziekenhuizen Leuven |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Evaluation of postoperatieve recovery | STANDARD QUESTIONS AT 1, 3, 6 AND 12 MONTHS FU | 1 YEAR |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00585312 -
Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)
|
Phase 3 | |
Completed |
NCT03095703 -
Sirolimus and Familial Adenomatous Polyposis (FAP)
|
Phase 2 | |
Completed |
NCT03649971 -
A Study of Guselkumab in Participants With Familial Adenomatous Polyposis
|
Phase 1 | |
Completed |
NCT05014360 -
A Study of JNJ-64251330 in Participants With Familial Adenomatous Polyposis
|
Phase 1 | |
Recruiting |
NCT05919264 -
FOG-001 in Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
Completed |
NCT02113202 -
Molecular Fluorescence Endoscopy in Patients With Familial Adenomatous Polyposis, Using Bevacizumab-IRDye800CW
|
Phase 1 | |
Withdrawn |
NCT03027401 -
Clinical Sequencing of Cancer and Tissue Repository: OncoGenomics
|
||
Recruiting |
NCT06435533 -
Cold Atmospheric Plasma for the Endoscopic Treatment of Duodenal Polyps in Patients With Familial Adenomatous Polyposis
|
N/A | |
Terminated |
NCT00140894 -
A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED)
|
Phase 4 | |
Active, not recruiting |
NCT01187901 -
A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients
|
Phase 2 | |
Recruiting |
NCT00319007 -
Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatous Polyposis
|
Phase 2 | |
No longer available |
NCT04948398 -
Post-Trial Access for Guselkumab in Participants With Familial Adenomatous Polyposis
|